Defend with Profend® nasal antiseptic kit to protect surgical and ICU patients from infections.

Profend_Nasal-Antiseptic_Kit_swabs_513x446_022025_nobackground Click here for a free sample of Profend

60-second application with Profend nasal swabs kills 99.7% of Staphylococcus aureus at 10 minutes.1

Simply effective infection prevention.

Profend PVP-Iodine nasal swabs take just 60 seconds for long-lasting reduction of S. aureus1

Visit product page

A quick, comfortable swab before surgery reduces the risk of SSIs*

More on comfort and compliance

Administer as needed to reduce the risk of CLABSIs2†

See CDC Prevention Strategies

See how Profend kits made a difference for infection prevention at
Hunterdon Medical Center in New Jersey.

Easy and efficient—just snap and swab.

  • Profend nasal antiseptic kits come in boxes of 4 swabs—use each swab for 15 seconds for a total of 60 seconds
  • Profend swabs are pre-saturated, mess-free—just snap open and use
  • More than 90% of healthcare providers surveyed prefer Profend kits over other PVP-Iodine products because they can be applied up to 2.5x faster3

Designed for comfort and compliance.

  • Profend nasal swabs have a slim, compact design for patient comfort
  • 96.6% of patients surveyed are comfortable with nasal application of PVP-Iodine4
  • Clinician-administered for 100% compliance

Reduce risk of healthcare-associated infections (HAIs).

Bacterial decolonization can help lower HAIs, length of stays, and costs5
CDC guideline recommends nasal decolonization as a core strategy to prevent surgical site infections2
As a PVP-Iodine antiseptic rather than an antibiotic, Profend kits support your antibiotic stewardship initiatives
Profend_Nasal-Antiseptic_Kit_swabs_660x750_022025_nobackground

Find out more about Profend with these helpful resources.

References

1.PDI in vivo Study 0113-CTEVO. 2.Centers for Disease Control and Prevention. Strategies to Prevent Hospital-onset Staphylococcus aureus Bloodstream Infections in Acute Care Facilities. https://www.cdc.gov/hai/prevent/staph-prevention-strategies.html. Published December 2019. Accessed December 10, 2020. 3.PDI user acceptance study. 4.Maslow J, Hutzler L, Cuff G, Rosenberg A, Phillips M, Bosco J. Patient experience with mupirocin or povidone-iodine nasal decolonization. Orthopedics. 2014;37(6):e576–e581. 5.Nelson R, Samore M, Smith K, et al. Cost-effectiveness of adding decolonization to a surveillance strategy of screening and isolation for methicillin-resistant Staphylococcus aureus carriers. Clin Microbiol Infect. 2010;16(12):1740–1746.

*Surgical site infections. †Central line-associated bloodstream infections.